Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Current Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Current Liabilities -----

What is the latest Current Liabilities ratio of GLAND PHARMA ?

The latest Current Liabilities ratio of GLAND PHARMA is - based on Mar2026 Consolidated results.
Year Current Liabilities
Mar2026-
Mar2025-
Mar2024-
Mar2023-
Mar2022-

How is Current Liabilities of GLAND PHARMA Trending?

Years Current Liabilities % Change
Mar2026 -
0
Mar2025 -
0
Mar2024 -
0
Mar2023 -
0
Mar2022 - -

Compare Current Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹47,327.8 Cr -1.3% 11.3% 49.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,180.0 Cr 1.6% -1% 22.2% Stock Analytics
DIVIS LABORATORIES ₹243,302.0 Cr 1.7% 10.1% 49.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,623.0 Cr 1.5% -1.2% 38.2% Stock Analytics
CIPLA ₹114,554.0 Cr 0.7% -3.5% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,741.0 Cr -1.3% 0.1% -7.8% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.3%

11.3%

49.8%

SENSEX

-0.9%

-1.5%

-5.8%


You may also like the below Video Courses